N.O. Pozdnyakov, A.L.Khokhlov
eNOS GENE POLYMORPHISM: PREVALENCE AND RELATIONSHIP WITH DISEASES
|
№13 / 2015
|
E.I. Chukanova, A.S. Chukanova
DISTINCT MECHANISMS OF PATHOGENESIS OF CEREBROVASCULAR INSUFFICIENCY
|
№13 / 2014
|
D.A. Gusakova, E.A. Efremov
PATHOGENETIC APPROACH TO THE USE OF ALPHA-LIPOIC ACID IN THE TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS
|
№12 / 2014
|
M.E. Statsenko, M.V. Derevyanchenko
FEATURES OF MANAGEMENT OF HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A VIEW OF CARDIOLOGIST
|
№16 / 2013
|
S.A. Zhivolupov, I.N. Samartsev
Modern Clinical Analysis Of Cerebrovascular Diseases: Key Issues Of Differential Diagnosis And Pathogenetic Treatment
|
№7 / 2012
|
T.E. Morozova, O.A. Vartanova
Potentials For Use Of Angiotensin-converting Enzyme Inhibitor Prestarium A In Correction Of Coronary And Myocardial Reserves In Patient With Coronary Heart Disease: Clinical Discussion
|
№15 / 2011
|
O.V. Zanozina
Possibility Of Correction Of Oxidative Stress In Patients With Diabetes Using Dibicor
|
№16 / 2010
|
I.V. Gur’eva
Therapeutic Potentials Of Benfotiamine
|
№16 / 2010
|